Non-Hodgkin lymphoma Posts Page 2 on Medivizor
Navigation Menu

Non-Hodgkin lymphoma Posts on Medivizor

The effectiveness of lenalidomide to treat patients with relapsed or refractory mantle cell lymphoma

Posted by on Dec 30, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study compared lenalidomide (Revlimid) with the doctor’s choice of medication in patients with relapsed or refractory mantle cell lymphoma. The study concluded that lenalidomide significantly improved outcomes for patients with mantle cell lymphoma. Some background Mantle cell lymphoma (MCL) is a type of non-Hodgkin...

Read More

How safe and effective is abexinostat in patients with relapsed/refractory NHL?

Posted by on Dec 29, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated the effects of abexinostat in patients with relapsed or refractory (did not respond to treatment) NHL (non-Hodgkin’s lymphoma). The study concluded that abexinostat is safe and effective in patients with NHL (particularly follicular lymphoma and diffuse large B-cell lymphoma). Some background Histone...

Read More

Peonies and Hope

Peonies and Hope

Posted by on Dec 23, 2017 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 2 comments

“People are like peonies, they need a good hard frost to bring out the character.” ~Francis “Doc” Winter “Doc” Winter was a Midwesterner.  Born in Iowa in 1931, in the midst of the Great Depression, he grew up on a small farm.  He knew about hard frosts. Struggle, pain and suffering are part of life.  Joy, love and...

Read More

Does biosimilar filgrastim improve neutropenia in older DLBCL patients receiving chemotherapy?

Posted by on Dec 20, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study analyzed the outcomes of older patients with stage 3 or 4 DLBCL (diffuse large B-cell lymphoma) who received biosimilar filgrastim (Neupogen) during their chemotherapy. The study concluded that filgrastim was safe and effective in these patients. Some background Diffuse large B-cell lymphoma (DLBCL) is the most common type...

Read More

Impact of multi-drug resistant organisms after stem cell transplantation

Posted by on Dec 16, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the impact of multi-drug resistant organisms in patients who had undergone stem cell treatment. The study concluded that patients colonized with multi-drug resistant organisms should be watched closely for infections after transplantation.  Some background Stem cell transplantation is a treatment used in...

Read More

CAR-T cell therapy and infection risk

Posted by on Dec 16, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined infection risk in leukemia and lymphoma patients treated with CAR-T cell therapy, a new type of immunotherapy. Researchers reported that infection rates were comparable to other salvage therapies.  Some background Chimeric antigen receptor (CAR) T-cell therapy helps the immune system to fight cancer cells. In...

Read More

CAR-T cell therapy and infection risk

Posted by on Dec 16, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined infection risk in leukemia and lymphoma patients treated with CAR-T cell therapy, a new type of immunotherapy. Researchers reported that infection rates were comparable to other salvage therapies.  Some background Chimeric antigen receptor (CAR) T-cell therapy helps the immune system to fight cancer cells. In...

Read More

NHL with central nervous system involvement: Autologous stem cell transplant after high-dose chemotherapy an effective treatment option

Posted by on Dec 12, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined outcomes of autologous stem cell transplants after high-dose chemotherapy in non-Hodgkin lymphoma (NHL) patients with central nervous system (CNS) involvement. This study reported durable remission and good disease control for NHL with CNS involvement.  Some background Many forms of NHL are treatable. When...

Read More

PTSD and Cancer

PTSD and Cancer

Posted by on Dec 11, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 2 comments

“I think all too often we underestimate the impact of a cancer diagnosis on the mental health and well-being of the individual, thus it goes unaddressed.” ~Stephanie Zimmerman, MSN Receiving a diagnosis of cancer can bring on feelings of worry, fear, dread, anger, uncertainty and loss.  Research indicates that, for some people, these symptoms of...

Read More

Effectiveness of bortezomib, cladribine, and rituximab in mantle cell and follicular lymphomas

Posted by on Dec 9, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the combination of bortezomib (Velcade), cladribine (Leustatin), and rituximab (Rituxan) for patients with mantle cell or follicular lymphoma. The authors concluded that this combination was effective and can be an alternative for patients who cannot undergo stem cell transplantation. Some background There is no...

Read More

Current treatment options for patients with relapsed or difficult to treat mantle cell lymphoma

Posted by on Dec 4, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This review explores the current treatments for patients with relapsed or difficult to treat mantle cell lymphoma.  Some background Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma. Patients with relapsed MCL generally have poor outcomes. These patients with relapsed or difficult to treat (refractory) MCL have...

Read More

The effectiveness of radiotherapy following autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Posted by on Dec 4, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effect of radiotherapy after autologous stem cell transplantation for patients with relapsed or difficult to treat diffuse large B-cell lymphoma. The study concluded that patients had better tumor control when treated with involved-field radiotherapy after autologous stem cell transplantation.  Some...

Read More